SCHEMBL2653386

SCHEMBL2653386

CC(CCc1ccc(C(=O)NCCC(=O)O)cc1F)COc1ccc(-c2ccc(C(F)(F)F)cc2)nc1

nearest known ligand 0.48

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
GCG P01275 4/20 0.48
GCGR P47871 18/20 0.46
GIPR P48546 5/20 0.46
GLP1R P43220 2/20 0.43
VIPR2 P41587 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2655266 0.90 GCG (0.55) GCGGCGRGIPRGLP1R
SCHEMBL3778469 0.86 GCG (0.53) GCGGCGRGIPRGLP1R
SCHEMBL2655286 0.85 GCG (0.53) GCGGCGRGIPR
SCHEMBL2655328 0.84 L3MBTL1 (0.49) GCGRGIPR
SCHEMBL2657520 0.82 GCG (0.56) GCGGCGRGIPR
SCHEMBL21529019 0.80 GCG (0.49) GCGGCGRGIPRGLP1R
SCHEMBL21529021 0.80 GCG (0.49) GCGGCGRGIPRGLP1R
SCHEMBL2654837 0.80 GCG (0.59) GCGGCGRGIPRGLP1R
SCHEMBL2654147 0.80 FFAR1 (0.48) GCGGCGRGIPR
SCHEMBL1765610 0.80 GCGR (0.56) GCGGCGRGIPRGLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758853-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 EP claimed
WO-2005123668-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-29 WO claimed
EP-1758853-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 EP disclosed
WO-2005123668-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-29 WO disclosed